Publications by authors named "B Beaudet"

Claim this Profile
P
Pharmacokinetics and pharmacodynamics utilizing unbound target tissue exposure as part of a disposition-based rationale for lead optimization of benzoxaboroles in the treatment of Stage 2 Human African Trypanosomiasis.
Stephen Wring, Eric Gaukel, Bakela Nare, Robert Jacobs, Beth Beaudet

Parasitology· January 2014

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
SCYX-7158, an orally-active benzoxaborole for the treatment of stage 2 human African trypanosomiasis.
Robert T Jacobs, Bakela Nare, Stephen A Wring, Matthew D Orr, Daitao Chen, Beth Beaudet

PLoS Negl Trop Dis· June 2011

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Discovery of novel orally bioavailable oxaborole 6-carboxamides that demonstrate cure in a murine model of late-stage central nervous system african trypanosomiasis.
Bakela Nare, Stephen Wring, Cyrus Bacchi, Beth Beaudet, Tana Bowling

Antimicrob Agents Chemother· October 2010

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
L
Lysosomes contribute to anomalous pharmacokinetic behavior of melanocortin-4 receptor agonists.
Yuping Gong, Zhiyang Zhao, Donavon J McConn, Beth Beaudet, Melanie Tallman

Pharm Res· June 2007

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Inhibition of tumor necrosis factor-alpha (TNF-alpha) production and arthritis in the rat by GW3333, a dual inhibitor of TNF-alpha-converting enzyme and matrix metalloproteinases.
J G Conway, R C Andrews, B Beaudet, D M Bickett, V Boncek

J Pharmacol Exp Ther· September 2001

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis